tiprankstipranks
Ge Healthcare Technologies Inc. (GEHC)
NASDAQ:GEHC
US Market
GEHC
GE Healthcare Technologies Inc
RESEARCH TOOLSreports
Want to see GEHC full AI Analyst Report?

GE Healthcare Technologies Inc (GEHC) Stock Forecast & Price Target

1,832 Followers
See the Price Targets and Ratings of:

GEHC Analyst Ratings

Moderate Buy
12Ratings
Moderate Buy
7 Buy
5 Hold
0 Sell
Based on 12 analysts giving stock ratings to
GE
Healthcare Technologies Inc
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

GEHC Stock 12 Month Forecast

Average Price Target

$79.09
▲(5.93% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for GE Healthcare Technologies Inc in the last 3 months. The average price target is $79.09 with a high forecast of $95.00 and a low forecast of $65.00. The average price target represents a 5.93% change from the last price of $74.66.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"60":"$60","69":"$69","78":"$78","87":"$87","96":"$96"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":95,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$95.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":79.0909090909091,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$79.09</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":65,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$65.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[60,69,78,87,96],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,61.03,63.643076923076926,66.25615384615385,68.86923076923077,71.4823076923077,74.09538461538462,76.70846153846153,79.32153846153847,81.93461538461538,84.5476923076923,87.16076923076923,89.77384615384615,92.38692307692307,{"y":95,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,61.03,62.4193006993007,63.8086013986014,65.1979020979021,66.58720279720279,67.9765034965035,69.3658041958042,70.75510489510489,72.1444055944056,73.5337062937063,74.923006993007,76.3123076923077,77.70160839160839,{"y":79.0909090909091,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,61.03,61.33538461538462,61.64076923076923,61.94615384615385,62.25153846153846,62.55692307692308,62.862307692307695,63.167692307692306,63.473076923076924,63.77846153846154,64.08384615384615,64.38923076923076,64.69461538461539,{"y":65,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":67.548,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.024,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.813,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.756,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.631,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.409,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.883,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.17,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.947,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.071,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.121,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.945,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":61.03,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$95.00Average Price Target$79.09Lowest Price Target$65.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
UBS Analyst forecast on GEHC
Graham Doyle
UBS
UBS
$75→$69
Hold
-7.58%
Downside
Upgraded
05/21/26
GE Healthcare Downgraded to Hold as Risk‑Reward Seen Balanced After 30% Share Slide and Lower‑Than‑Consensus EPS Outlook
Oppenheimer Analyst forecast on GEHC
Suraj Kalia
Oppenheimer
Oppenheimer
$89→$85
Buy
13.85%
Upside
Assigned
04/30/26
GE HealthCare price target lowered to $85 from $89 at OppenheimerGE HealthCare price target lowered to $85 from $89 at Oppenheimer
J.P. Morgan Analyst forecast on GEHC
Robbie Marcus
J.P. Morgan
J.P. Morgan
$80→$65
Hold
-12.94%
Downside
Reiterated
04/30/26
GE HealthCare price target lowered to $65 from $80 at JPMorganGE HealthCare price target lowered to $65 from $80 at JPMorgan
Mizuho Securities Analyst forecast on GEHC
Anthony Petrone
Mizuho Securities
Mizuho Securities
$90→$80
Buy
7.15%
Upside
Reiterated
04/30/26
Mizuho Securities Remains a Buy on GE Healthcare Technologies Inc (GEHC)
Barclays Analyst forecast on GEHC
Matt Miksic
Barclays
Barclays
$87→$78
Hold
4.47%
Upside
Reiterated
04/30/26
Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (NYSE: HNGE), Ionis Pharmaceuticals (NASDAQ: IONS) and GE Healthcare Technologies Inc (NASDAQ: GEHC)
Citi Analyst forecast on GEHC
Joanne Wuensch
Citi
Citi
$80→$65
Hold
-12.94%
Downside
Reiterated
04/30/26
GE Healthcare Kept at Hold as Analyst Cuts Price Target to $65 on Margin Pressure and Execution Risks
Evercore ISI Analyst forecast on GEHC
Vijay Kumar
Evercore ISI
Evercore ISI
$85→$80
Buy
7.15%
Upside
Reiterated
04/30/26
GE HealthCare price target lowered to $80 from $85 at Evercore ISIGE HealthCare price target lowered to $80 from $85 at Evercore ISI
Goldman Sachs Analyst forecast on GEHC
David Roman
Goldman Sachs
Goldman Sachs
―
Hold
―
Downgraded
04/30/26
Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (NYSE: TEVA), GE Healthcare Technologies Inc (NASDAQ: GEHC) and Crescent Biopharma (NASDAQ: CBIO)
Stifel Nicolaus Analyst forecast on GEHC
Rick Wise
Stifel Nicolaus
Stifel Nicolaus
$98→$80
Buy
7.15%
Upside
Reiterated
04/29/26
GE HealthCare price target lowered to $80 from $98 at StifelGE HealthCare price target lowered to $80 from $98 at Stifel
BTIG Analyst forecast on GEHC
Ryan Zimmerman
BTIG
BTIG
$85
Buy
13.85%
Upside
Reiterated
04/21/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Biogen (NASDAQ: BIIB), Nektar Therapeutics (NASDAQ: NKTR) and GE Healthcare Technologies Inc (NASDAQ: GEHC)
Piper Sandler Analyst forecast on GEHC
Jason Bednar
Piper Sandler
Piper Sandler
$94→$88
Buy
17.87%
Upside
Reiterated
04/17/26
Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (NASDAQ: GEHC), Immunome (NASDAQ: IMNM) and Eli Lilly & Co (NYSE: LLY)
Argus Research Analyst forecast on GEHC
David Toung
Argus Research
Argus Research
$95
Buy
27.24%
Upside
Assigned
03/03/26
GE HealthCare price target raised to $95 from $90 at ArgusGE HealthCare price target raised to $95 from $90 at Argus
Jefferies Analyst forecast on GEHC
Matthew Taylor
Jefferies
Jefferies
$105
Buy
40.64%
Upside
Reiterated
02/18/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Wells Fargo Analyst forecast on GEHC
Larry Biegelsen
Wells Fargo
Wells Fargo
$95→$97
Buy
29.92%
Upside
Reiterated
02/05/26
Wells Fargo Remains a Buy on GE Healthcare Technologies Inc (GEHC)
Morgan Stanley Analyst forecast on GEHC
Patrick Wood
Morgan Stanley
Morgan Stanley
$80→$85
Hold
13.85%
Upside
Reiterated
02/05/26
GE HealthCare price target raised to $85 from $80 at Morgan StanleyGE HealthCare price target raised to $85 from $80 at Morgan Stanley
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
UBS Analyst forecast on GEHC
Graham Doyle
UBS
UBS
$75→$69
Hold
-7.58%
Downside
Upgraded
05/21/26
GE Healthcare Downgraded to Hold as Risk‑Reward Seen Balanced After 30% Share Slide and Lower‑Than‑Consensus EPS Outlook
Oppenheimer Analyst forecast on GEHC
Suraj Kalia
Oppenheimer
Oppenheimer
$89→$85
Buy
13.85%
Upside
Assigned
04/30/26
GE HealthCare price target lowered to $85 from $89 at OppenheimerGE HealthCare price target lowered to $85 from $89 at Oppenheimer
J.P. Morgan Analyst forecast on GEHC
Robbie Marcus
J.P. Morgan
J.P. Morgan
$80→$65
Hold
-12.94%
Downside
Reiterated
04/30/26
GE HealthCare price target lowered to $65 from $80 at JPMorganGE HealthCare price target lowered to $65 from $80 at JPMorgan
Mizuho Securities Analyst forecast on GEHC
Anthony Petrone
Mizuho Securities
Mizuho Securities
$90→$80
Buy
7.15%
Upside
Reiterated
04/30/26
Mizuho Securities Remains a Buy on GE Healthcare Technologies Inc (GEHC)
Barclays Analyst forecast on GEHC
Matt Miksic
Barclays
Barclays
$87→$78
Hold
4.47%
Upside
Reiterated
04/30/26
Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (NYSE: HNGE), Ionis Pharmaceuticals (NASDAQ: IONS) and GE Healthcare Technologies Inc (NASDAQ: GEHC)
Citi Analyst forecast on GEHC
Joanne Wuensch
Citi
Citi
$80→$65
Hold
-12.94%
Downside
Reiterated
04/30/26
GE Healthcare Kept at Hold as Analyst Cuts Price Target to $65 on Margin Pressure and Execution Risks
Evercore ISI Analyst forecast on GEHC
Vijay Kumar
Evercore ISI
Evercore ISI
$85→$80
Buy
7.15%
Upside
Reiterated
04/30/26
GE HealthCare price target lowered to $80 from $85 at Evercore ISIGE HealthCare price target lowered to $80 from $85 at Evercore ISI
Goldman Sachs Analyst forecast on GEHC
David Roman
Goldman Sachs
Goldman Sachs
―
Hold
―
Downgraded
04/30/26
Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (NYSE: TEVA), GE Healthcare Technologies Inc (NASDAQ: GEHC) and Crescent Biopharma (NASDAQ: CBIO)
Stifel Nicolaus Analyst forecast on GEHC
Rick Wise
Stifel Nicolaus
Stifel Nicolaus
$98→$80
Buy
7.15%
Upside
Reiterated
04/29/26
GE HealthCare price target lowered to $80 from $98 at StifelGE HealthCare price target lowered to $80 from $98 at Stifel
BTIG Analyst forecast on GEHC
Ryan Zimmerman
BTIG
BTIG
$85
Buy
13.85%
Upside
Reiterated
04/21/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Biogen (NASDAQ: BIIB), Nektar Therapeutics (NASDAQ: NKTR) and GE Healthcare Technologies Inc (NASDAQ: GEHC)
Piper Sandler Analyst forecast on GEHC
Jason Bednar
Piper Sandler
Piper Sandler
$94→$88
Buy
17.87%
Upside
Reiterated
04/17/26
Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (NASDAQ: GEHC), Immunome (NASDAQ: IMNM) and Eli Lilly & Co (NYSE: LLY)
Argus Research Analyst forecast on GEHC
David Toung
Argus Research
Argus Research
$95
Buy
27.24%
Upside
Assigned
03/03/26
GE HealthCare price target raised to $95 from $90 at ArgusGE HealthCare price target raised to $95 from $90 at Argus
Jefferies Analyst forecast on GEHC
Matthew Taylor
Jefferies
Jefferies
$105
Buy
40.64%
Upside
Reiterated
02/18/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Wells Fargo Analyst forecast on GEHC
Larry Biegelsen
Wells Fargo
Wells Fargo
$95→$97
Buy
29.92%
Upside
Reiterated
02/05/26
Wells Fargo Remains a Buy on GE Healthcare Technologies Inc (GEHC)
Morgan Stanley Analyst forecast on GEHC
Patrick Wood
Morgan Stanley
Morgan Stanley
$80→$85
Hold
13.85%
Upside
Reiterated
02/05/26
GE HealthCare price target raised to $85 from $80 at Morgan StanleyGE HealthCare price target raised to $85 from $80 at Morgan Stanley
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering GE Healthcare Technologies Inc

3 Months
Larry BiegelsenWells Fargo
Success Rate
12/21 ratings generated profit
57%
Average Return
+0.25%
Copying Larry Biegelsen's trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +0.25% per trade.
1 Year
Anthony PetroneMizuho Securities
Success Rate
6/15 ratings generated profit
40%
Average Return
-0.79%
Copying Anthony Petrone's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -0.79% per trade.
2 Years
Larry BiegelsenWells Fargo
Success Rate
6/21 ratings generated profit
29%
Average Return
-10.61%
Copying Larry Biegelsen's trades and holding each position for 2 Years would result in 28.57% of your transactions generating a profit, with an average return of -10.61% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GEHC Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
0
0
0
0
0
Buy
17
17
15
19
14
Hold
10
7
8
11
9
Sell
2
2
2
0
0
Strong Sell
0
0
0
0
0
total
29
26
25
30
23
In the current month, GEHC has received 14 Buy Ratings, 9 Hold Ratings, and 0 Sell Ratings. GEHC average Analyst price target in the past 3 months is 79.09.
Each month's total comprises the sum of three months' worth of ratings.

GEHC Financial Forecast

GEHC Earnings Forecast

Next quarter’s earnings estimate for GEHC is $1.03 with a range of $1.01 to $1.05. The previous quarter’s EPS was $0.99. GEHC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year GEHC has Performed in-line its overall industry.
Next quarter’s earnings estimate for GEHC is $1.03 with a range of $1.01 to $1.05. The previous quarter’s EPS was $0.99. GEHC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year GEHC has Performed in-line its overall industry.

GEHC Sales Forecast

Next quarter’s sales forecast for GEHC is $5.27B with a range of $5.19B to $5.33B. The previous quarter’s sales results were $5.13B. GEHC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year GEHC has Performed in-line its overall industry.
Next quarter’s sales forecast for GEHC is $5.27B with a range of $5.19B to $5.33B. The previous quarter’s sales results were $5.13B. GEHC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year GEHC has Performed in-line its overall industry.

GEHC Stock Forecast FAQ

What is GEHC’s average 12-month price target, according to analysts?
Based on analyst ratings, Ge Healthcare Technologies Inc.’s 12-month average price target is 79.09.
    What is GEHC’s upside potential, based on the analysts’ average price target?
    Ge Healthcare Technologies Inc. has 5.93% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is GEHC a Buy, Sell or Hold?
          Ge Healthcare Technologies Inc. has a consensus rating of Moderate Buy which is based on 7 buy ratings, 5 hold ratings and 0 sell ratings.
            What is Ge Healthcare Technologies Inc.’s price target?
            The average price target for Ge Healthcare Technologies Inc. is 79.09. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $95.00 ,the lowest forecast is $65.00. The average price target represents 5.93% Increase from the current price of $74.66.
              What do analysts say about Ge Healthcare Technologies Inc.?
              Ge Healthcare Technologies Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.
                How can I buy shares of GEHC?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.